Overview

This trial is active, not recruiting.

Condition fibromyalgia
Treatments kinesio taping and inhibitory treatment techniques, exercise and electrical stimulation therapy
Sponsor Universidad de Almeria
Start date August 2016
End date March 2017
Trial size 64 participants
Trial identifier NCT02859467, UAL-496

Summary

Objective: Compare the benefits of Kinesio Taping and Inhibitory Treatment Techniques for Cervical, Thoracic and Lumbar Spine in Patients with Fibromyalgia Syndrome (FMS).

Study Design: A single-blind randomized controlled trial was conducted on patients with FMS.

Setting: Clinical setting. Methods: Sixty-four subjects with FMS were randomly assigned to an experimental group receiving kinesio taping and inhibitory treatment techniques, or to a control group for exercises and electrical stimulation therapy.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation randomized
Endpoint classification efficacy study
Intervention model parallel assignment
Masking single blind (outcomes assessor)
Primary purpose treatment
Arm
(Experimental)
During each session participants will receive the application kinesio taping in trapezius, infraspinatus and paravertebral muscles. Inhibitory Treatment Techniques: Release Technique of the trapezius muscle. Release Technique for scalene muscles. Technique suboccipital inhibition. Technique hands crossed for induction dorsal superficial fascia.
kinesio taping and inhibitory treatment techniques
Kinesio Taping on trapezius, infraspinatus, and paravertebral muscles Inhibitory Treatment Techniques: Release Technique of the trapezius muscle. Release Technique for scalene muscles. Technique suboccipital inhibition. Technique hands crossed for induction dorsal superficial fascia.
(Active Comparator)
Session for general physical activities (joint mobility, muscle strength and elasticity), and electrical stimulation therapy on para vertebral muscles.
exercise and electrical stimulation therapy
Session for general physical activities (joint mobility, muscle strength and elasticity), and electrical stimulation therapy on para vertebral muscles.

Primary Outcomes

Measure
Pain Intensity
time frame: Changes from Baseline, and 10 weeks

Secondary Outcomes

Measure
Quality of Life (SF-36)
time frame: Changes from Baseline, and 10 weeks
Pittsburgh Quality of Sleep Questionnaire
time frame: Changes from Baseline, and 10 weeks
Beck Inventory for Depression
time frame: Changes from Baseline, and 10 weeks
Fibromyalgia Impact Questionnaire (FIQ)
time frame: Changes from Baseline, and 10 weeks
Hospital Anxiety Depression Scale (HADS)
time frame: Changes from Baseline, and 10 weeks
State-Trait Anxiety Inventory (STAI)
time frame: Changes from Baseline, and 10 weeks
McGill Pain Questionnaire
time frame: Changes from Baseline, and 10 weeks
Fatigue Impact Scale
time frame: Changes from Baseline, and 10 weeks
Pain Pressure
time frame: Changes from Baseline, and 10 weeks
Schöber Test
time frame: Changes from Baseline, and 10 weeks
Widespread pain index
time frame: Changes from Baseline, and 10 weeks
Symptom severity score
time frame: Changes from Baseline, and 10 weeks
Measurement Finger-Floor
time frame: symptom severity scale

Eligibility Criteria

Male or female participants from 18 years up to 65 years old.

Inclusion Criteria: - Diagnosed Fibromyalgia Syndrome. - Limitation of usual activities due to pain on at least 1 day in the previous 30 days. - Agreement to attend evening therapy sessions. - Non-practice of regular physical activity. Exclusion Criteria: - A history of surgery. - The presence of comorbid conditions (e.g., morbid obesity, inflammatory diseases, irritable bowel syndrome and interstitial cystitis). - A history of whiplash injury. - Severe physical disability. - uncontrolled endocrine disorders (e.g., hyperthyroidism, diabetes); 6) illness (e.g., schizophrenia or substance abuse). - The use of medication other than as-needed analgesics (excluding long-term narcotics). - Malignancy. - Psychiatric disorders. - A score of ≥ 9 points in the Beck depression inventory.

Additional Information

Official title Benefits of Kinesio Taping and Inhibitory Treatment Techniques in Patients With Fibromyalgia Syndrome
Trial information was received from ClinicalTrials.gov and was last updated in September 2016.
Information provided to ClinicalTrials.gov by Universidad de Almeria.